Abstract:
BACKGROUND:Prostate cancer (PCa) is the second most common disease among men worldwide. It is important to know survival outcomes and prognostic factors for this disease. Recruitment for the largest therapeutic randomised controlled trial in PCa--the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial (STAMPEDE)--includes men with newly diagnosed metastatic PCa who are commencing long-term androgen deprivation therapy (ADT); the control arm provides valuable data for a prospective cohort. OBJECTIVE:Describe survival outcomes, along with current treatment standards and factors associated with prognosis, to inform future trial design in this patient group. DESIGN, SETTING, AND PARTICIPANTS:STAMPEDE trial control arm comprising men newly diagnosed with M1 disease who were recruited between October 2005 and January 2014. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS:Overall survival (OS) and failure-free survival (FFS) were reported by primary disease characteristics using Kaplan-Meier methods. Hazard ratios and 95% confidence intervals (CIs) were derived from multivariate Cox models. RESULTS AND LIMITATIONS:A cohort of 917 men with newly diagnosed M1 disease was recruited to the control arm in the specified interval. Median follow-up was 20 mo. Median age at randomisation was 66 yr (interquartile range [IQR]: 61-71), and median prostate-specific antigen level was 112 ng/ml (IQR: 34-373). Most men (n=574; 62%) had bone-only metastases, whereas 237 (26%) had both bone and soft tissue metastases; soft tissue metastasis was found mainly in distant lymph nodes. There were 238 deaths, 202 (85%) from PCa. Median FFS was 11 mo; 2-yr FFS was 29% (95% CI, 25-33). Median OS was 42 mo; 2-yr OS was 72% (95% CI, 68-76). Survival time was influenced by performance status, age, Gleason score, and metastases distribution. Median survival after FFS event was 22 mo. Trial eligibility criteria meant men were younger and fitter than general PCa population. CONCLUSIONS:Survival remains disappointing in men presenting with M1 disease who are started on only long-term ADT, despite active treatments being available at first failure of ADT. Importantly, men with M1 disease now spend the majority of their remaining life in a state of castration-resistant relapse. PATIENT SUMMARY:Results from this control arm cohort found survival is relatively short and highly influenced by patient age, fitness, and where prostate cancer has spread in the body.
journal_name
Eur Uroljournal_title
European urologyauthors
James ND,Spears MR,Clarke NW,Dearnaley DP,De Bono JS,Gale J,Hetherington J,Hoskin PJ,Jones RJ,Laing R,Lester JF,McLaren D,Parker CC,Parmar MKB,Ritchie AWS,Russell JM,Strebel RT,Thalmann GN,Mason MD,Sydes MRdoi
10.1016/j.eururo.2014.09.032subject
Has Abstractpub_date
2015-06-01 00:00:00pages
1028-1038issue
6eissn
0302-2838issn
1873-7560pii
S0302-2838(14)00969-5journal_volume
67pub_type
杂志文章,随机对照试验相关文献
EUROPEAN UROLOGY文献大全abstract:BACKGROUND:Well-designed randomized controlled trials (RCTs) have the potential to provide high-quality evidence to inform questions of therapy and prevention, but this potential is contingent on the use of appropriate methods and transparent reporting. OBJECTIVE:To systematically assess the quality of urology RCT rep...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2016.07.042
更新日期:2016-12-01 00:00:00
abstract:OBJECTIVES:Sacral neuromodulation represents chronic stimulation of the sacral (S3) nerve. So far, the mode of action and neuro-anatomical basis is unclear. Sacral reflex mechanisms as well as pontine or cortical centers of modulation have been postulated. Our aim was to evaluate possible alterations in electroencephal...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/s0302-2838(02)00029-5
更新日期:2002-05-01 00:00:00
abstract::There are several surgical procedures for the correction of primary vesicoureteral reflux. Among them, the one of increasing success for its safety and effectiveness is that introduced by Gil Vernet at the beginning of the 1980s, primarily in the pediatric field. By the time of this study, its use had been extended to...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000474294
更新日期:1993-01-01 00:00:00
abstract::An improved shock wave source is required for the extended application of extracorporeal lithotripsy in proven and anticipated novel fields of therapy. Fundamental research was performed in the domains: disintegration efficiency; hydrophone stability; absolute calibration, and source optimization. The combined experie...
journal_title:European urology
pub_type: 杂志文章
doi:
更新日期:1991-01-01 00:00:00
abstract:OBJECTIVE:The objective of this research is to identify and determine the relative importance of dietary and environmental risk and risk reduction factors for prostate cancer mortality. MATERIALS AND METHODS:A multicountry ecologic approach was used in multivariate regression analyses with prostate cancer mortality ra...
journal_title:European urology
pub_type: 杂志文章,多中心研究
doi:10.1016/j.eururo.2003.08.018
更新日期:2004-03-01 00:00:00
abstract:BACKGROUND:Single-port robotic surgery is being adopted for various surgical procedures. There have been interest in and clinical use of single-port robot-assisted radical prostatectomy (spRARP), but little reported data on feasibility and early outcomes. OBJECTIVE:To describe our institution's initial experience with...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2019.04.001
更新日期:2020-03-01 00:00:00
abstract::Serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) were evaluated with double monoclonal radioimmunoassays. In 250 patients with prostatic cancer the normal limits were as follows: PSA 0.1-2.7 ng/ml, and PAP 1.09 +/- 0.45 ng/ml (mean +/- SD). In 91 untreated patients with non-metastatic tumour...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000472596
更新日期:1986-01-01 00:00:00
abstract::Casodex (bicalutamide, Zeneca Limited) is a nonsteroidal competitive inhibitor of androgens at the androgen receptor. The drug was developed to fulfil a number of needs for the treatment of prostate cancer. The specific aim was to demonstrate pharmacological activity, which would translate into clinical efficacy, good...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1159/000473847
更新日期:1996-01-01 00:00:00
abstract:CONTEXT:Robot-assisted surgery is increasingly used for radical cystectomy (RC) and urinary reconstruction. Sufficient data have accumulated to allow evidence-based consensus on key issues such as perioperative management, comparative effectiveness on surgical complications, and oncologic short- to midterm outcomes. O...
journal_title:European urology
pub_type: 共识发展会议,杂志文章,实务指引,评审
doi:10.1016/j.eururo.2014.12.009
更新日期:2015-03-01 00:00:00
abstract:BACKGROUND:Limited data on patterns of recurrence (local or metastatic) after salvage radical prostatectomy (SP) is available. OBJECTIVE:To examine biochemical, local and metastatic patterns of recurrence in patients undergoing SP for radiation-recurrent prostate cancer. DESIGN, SETTING, AND PARTICIPANTS:146 patients...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2008.07.007
更新日期:2009-02-01 00:00:00
abstract:OBJECTIVES:To design a proper follow-up for cystectomy and ileal conduit urinary diversion for primary bladder transitional carcinoma, we compared the radiographic characteristics of recurrent malignant upper tract lesions with those of benign ureteroileal anastomosis strictures. METHODS:Over a 20-year period, we foll...
journal_title:European urology
pub_type: 杂志文章
doi:
更新日期:1996-01-01 00:00:00
abstract:OBJECTIVE:evaluation of a self-injection program with a mixture of papaverine, phentolamine and prostaglandin E1 (PGE1). METHOD:a self-injection program for erectile dysfunction was started by 48 patients, using a 1-ml mixture of 4.5 mg papaverine, 0.2 mg phentolamine and 1.5 micrograms PGE1. Patients completed a ques...
journal_title:European urology
pub_type: 临床试验,杂志文章
doi:10.1159/000475407
更新日期:1994-01-01 00:00:00
abstract::Sentinel lymph node (SLN) detection techniques have the potential to change the standard of surgical care for patients with prostate cancer. We performed a lymphatic mapping study and determined the value of fluorescence SLN detection with indocyanine green (ICG) for the detection of lymph node metastases in intermedi...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2016.01.034
更新日期:2016-11-01 00:00:00
abstract::Cytogenetic and flow cytometric DNA analyses were performed on 37 tumor samples from 16 patients with renal cell carcinoma. 36 cultures were chromosomally abnormal and 1 was normal. The most frequent abnormality was trisomy or tetrasomy of chromosome 7 (13 of 16 tumors), suggesting that this abnormality might be a pri...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000473581
更新日期:1991-01-01 00:00:00
abstract:CONTEXT:No single large published randomized controlled trial (RCT) has confirmed the efficacy of virtual simulators in the acquisition of skills to the standard required for safe clinical robotic surgery. This remains the main obstacle for the adoption of these virtual simulators in surgical residency curricula. OBJE...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1016/j.eururo.2015.09.021
更新日期:2016-06-01 00:00:00
abstract:CONTEXT:Enhanced recovery after surgery (ERAS) protocols aim to improve surgical outcomes by reducing variation in perioperative best practices. However, among published studies, results show a striking variation in the effect of ERAS pathways on perioperative outcomes after cystectomy. OBJECTIVE:To perform a systemat...
journal_title:European urology
pub_type: 杂志文章,meta分析,评审
doi:10.1016/j.eururo.2016.05.031
更新日期:2016-12-01 00:00:00
abstract:OBJECTIVE:TUNA has been demonstrated to be a safe and effective therapy for BPH. However the major criticism, as with all alternative treatments for BPH, was the lack of long-term data. We present the clinical outcome of patients treated by TUNA and followed for 5 years. METHODS:188 consecutive patients with symptomat...
journal_title:European urology
pub_type: 临床试验,杂志文章,多中心研究
doi:10.1016/s0302-2838(03)00218-5
更新日期:2003-07-01 00:00:00
abstract:OBJECTIVE:Assessment of the long-term morbidity of the upper urinary tract and of the voiding pattern in men with an ileal orthotopic bladder substitute with an afferent tubular segment. MATERIALS AND METHODS:Men surviving more than 5 years after radical cystectomy and orthotopic bladder substitution were evaluated. T...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2004.07.009
更新日期:2004-11-01 00:00:00
abstract:OBJECTIVES AND METHODS:The effects of double pigtail ureteric catheters (JJS) and percutaneous nephrostomies (PN) on ureteric motility and artificial stone transit was assessed in 12 dogs. Each animal underwent bilateral nephrostomies and an artificial stone insertion into each upper ureter (n = 20). A 4-Fr JJS was ins...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000474413
更新日期:1997-01-01 00:00:00
abstract:BACKGROUND:Dissimilarities in management and outcomes exist between upper tract urothelial carcinoma (UTUC) and urothelial carcinoma of the bladder (UCB). OBJECTIVE:The aim of this study was to analyze the stage-specific impact of upper or lower urinary tract tumor location on oncologic outcomes. DESIGN, SETTING, AND...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2012.02.018
更新日期:2012-10-01 00:00:00
abstract::We retrospectively studied the effect of perioperative blood transfusion in 208 transfused and 50 nontransfused patients operated on during a 12-year period for renal cell cancer. The 5-year renal cell cancer specific survival rate was 0.46 in the transfused patients versus 0.62 in the nontransfused patients. However,...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000475365
更新日期:1994-01-01 00:00:00
abstract:BACKGROUND:Previous studies in humans, dogs, and rats have shown that intraprostatic injection of botulinum neurotoxin type A (BoNTA) reduces gland size. OBJECTIVE:To investigate the role of eventual impairment of sympathetic, parasympathetic, and sensory nerves to gland atrophy after intraprostatic BoNTA administrati...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2008.07.003
更新日期:2009-07-01 00:00:00
abstract:BACKGROUND:Robot-assisted thrombectomy (RAT) for inferior vena cava (IVC) thrombus (RAT-IVCT) is being increasingly reported. However, the techniques and indications for robot-assisted cavectomy (RAC) for IVC thrombus are not well described. OBJECTIVE:To develop a decision-making program and analyze multi-institutiona...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2020.03.020
更新日期:2020-10-01 00:00:00
abstract:AIMS:It is the aim of these studies to derive a numerically defined progression index for prostatic intraepithelial neoplasia (PIN) lesions. METHODS:Histometric and karyometric features were automatically extracted from images of histopathologic sections by a machine vision system. RESULTS:Both histometric and karyom...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1159/000019884
更新日期:1999-01-01 00:00:00
abstract:OBJECTIVE:The aim of this study was to compare the effects of the nonsteroidal antiandrogen flutamide plus the LH-RH analogue goserelin acetate (combined androgen blockade [CAB]) with goserelin acetate alone in patients with advanced prostate cancer. The original analyses at 25 and 56 months of follow-up have been repo...
journal_title:European urology
pub_type: 临床试验,杂志文章,多中心研究,随机对照试验
doi:10.1159/000020119
更新日期:2000-02-01 00:00:00
abstract:OBJECTIVES:To assess the opinion amongst the international urological community on whether benign prostatic hyperplasia (BPH) is a progressive disease. METHODS:A 15-item questionnaire was distributed to the mailing list of the publication European Urology Today as well as being accessed through the website of the Euro...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/s0302-2838(02)00065-9
更新日期:2002-05-01 00:00:00
abstract::The burden of prostate cancer is increasing. Therefore, we need to implement a contemporary, organized, risk-stratified program for early detection to reduce both the harm from the disease and potential overdiagnosis and overtreatment, while avoiding underdiagnosis to considerably improve the harm-to-benefit ratio. ...
journal_title:European urology
pub_type: 社论
doi:10.1016/j.eururo.2020.12.010
更新日期:2020-12-28 00:00:00
abstract:OBJECTIVES:To assess the factors effecting PSA bounce and to identify any possible relationship with biochemical control after 3-D conformal radiotherapy (3D-CRT) and total androgen deprivation (TAD) for prostate cancer by evaluating four previously described PSA bounce definitions. METHODS:Between January 1998 and Ja...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2005.04.007
更新日期:2005-07-01 00:00:00
abstract:OBJECTIVES:Prostaglandin E2 (PGE2) is a potent immune modulator and known to suppress both tumour antigen-specific helper T (TH1) cells and the generation of cytotoxic T lymphocytes (CTLs). We hypothesised that a combination of the cyclooxygenase 2 (COX-2) selective inhibitor celecoxib and intravesical bacillus Calmett...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2008.01.013
更新日期:2008-09-01 00:00:00
abstract::Results from the ERA 223 trial of abiraterone combined with radium-223 among men with chemotherapy-naïve castration-resistant prostate cancer and bone metastases show no improvement in survival free from symptomatic skeletal events. We hypothesize that this finding might be attributable to bone loss induced by the con...
journal_title:European urology
pub_type: 评论,社论
doi:10.1016/j.eururo.2019.01.026
更新日期:2019-06-01 00:00:00